Startups
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
Overview
Location
United Kingdom, England, Oxford
Employees
1-10
Founded date
2021
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Empirical Ventures | empiricalventures.vc | |
| Longevitytech Fund | longevitytech.fund |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 25, 2022 | MitoRx Therapeutics Raises Seed Financing | MitoRx Therapeutics, an Oxford, England, UK-based biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, closed its seed financing. The financial detail... |
Reviews 0
FAQ about MitoRx Therapeutics
When was MitoRx Therapeutics founded?
MitoRx Therapeutics was founded in 2021.
Who has invested in MitoRx Therapeutics?
Parsers VC lists 3 investors of MitoRx Therapeutics, among them Empirical Ventures and Longevitytech Fund.
What has the press written about MitoRx Therapeutics?
Parsers VC has collected 2 articles mentioning MitoRx Therapeutics, among them “MitoRx Therapeutics Raises Seed Financing” (Apr 25, 2022).
Is MitoRx Therapeutics still active?
Yes, MitoRx Therapeutics is active; its latest activity on Parsers VC dates from Dec 14, 2023.